Biontech Covid-19 Vaccine
-
{
- All
- News
-
BioNTech Says 'No Evidence' Its Jabs Need Adapting For COVID-19 Variants
German firm BioNTech said Monday that the Covid-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
-
BioNTech Eyes Covid Vaccine For 12-15 Year Olds From June In Europe
BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June.
-
Pfizer, BioNTech Launch COVID-19 Vaccine Trial In Children Under 12
Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the U.S. drugmaker said on Thursday.
-
BioNTech-Pfizer Pledges 75 Million More Vaccine Doses To European Union
BioNTech and Pfizer said Monday they will ramp up their coronavirus vaccine deliveries to the European Union, pledging to send up to 75 million extra doses to the bloc in the spring.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Vaccine "Neutralises" Key Mutation In UK, South Africa Virus Strains: BioNTech
German company BioNTech said Friday a preliminary study shows that its vaccine works against the key mutation in coronavirus variants uncovered in Britain and South Africa.
-
WHO Europe Urges "Safe Compromise" On Timing Of Covid Vaccine Doses
European countries rolling out the Pfizer-BioNTech COVID-19 vaccine should be flexible on the time between the first and second doses, the World Health Organization's director for the region said on Thursday.
-
WHO Recommends 2 Doses Of Pfizer Covid Vaccine Within 21-28 Days
COVID-19 patients should take two doses of the new Pfizer/BioNTech vaccine within a period of 21-28 days, the head of the World Health Organization's immunization advisory group said on Tuesday.
-
No Evidence Covid Vaccine Will Work If Booster Dose Delayed: BioNTech
BioNTech and partner Pfizer warned on Monday that they had no evidence that their jointly developed vaccine will continue to protect against COVID-19 if the booster shot is given later than tested in trials.
-
Bulgaria Reports 4 Cases Of Side Effects From Pfizer Covid Vaccine
Four Bulgarians vaccinated against COVID-19 with the Pfizer/BioNTech vaccine developed mild to moderate side effects, Bulgarian Drug Agency executive director Bogdan Kirilov said on Monday.
-
BioNtech Founders Warn Of Covid Vaccine Supply Gaps: Report
BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.
-
US Nurse Tests Positive Over A Week After Receiving Pfizer Vaccine: Report
A 45-year-old nurse in California tested positive for COVID-19 more than a week after receiving Pfizer Inc's coronavirus vaccine, an ABC News affiliate reported on Tuesday.
-
Singapore Begins COVID-19 Vaccinations With Pfizer In One Of Asia's First
Singapore began vaccinating healthcare workers with Pfizer-BioNTech's COVID-19 vaccine on Wednesday, kicking off one of Asia's first inoculation programmes against a pandemic that has killed more than 1.7 million people globally.
-
Europe Begins Covid Vaccine Rollout Amid Fear Of New Virus Strain
A swath of EU nations begin vaccinating their most vulnerable groups Sunday as a reputedly more contagious coronavirus variant spread internationally and the WHO warned that the current pandemic would not be the last.
-
France Receives First Doses Of Pfizer COVID-19 Vaccine
France's first doses of the Pfizer-BioNTech coronavirus vaccine were delivered early Saturday to the Paris hospital system's central pharmacy outside the capital, an AFP journalist saw.
-
BioNTech Says 'No Evidence' Its Jabs Need Adapting For COVID-19 Variants
German firm BioNTech said Monday that the Covid-19 vaccine it developed with Pfizer does not require any modifications at the moment to protect against variants of the virus.
-
BioNTech Eyes Covid Vaccine For 12-15 Year Olds From June In Europe
BioNTech said Thursday that it expected its Covid-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June.
-
Pfizer, BioNTech Launch COVID-19 Vaccine Trial In Children Under 12
Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the U.S. drugmaker said on Thursday.
-
BioNTech-Pfizer Pledges 75 Million More Vaccine Doses To European Union
BioNTech and Pfizer said Monday they will ramp up their coronavirus vaccine deliveries to the European Union, pledging to send up to 75 million extra doses to the bloc in the spring.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Vaccine "Neutralises" Key Mutation In UK, South Africa Virus Strains: BioNTech
German company BioNTech said Friday a preliminary study shows that its vaccine works against the key mutation in coronavirus variants uncovered in Britain and South Africa.
-
WHO Europe Urges "Safe Compromise" On Timing Of Covid Vaccine Doses
European countries rolling out the Pfizer-BioNTech COVID-19 vaccine should be flexible on the time between the first and second doses, the World Health Organization's director for the region said on Thursday.
-
WHO Recommends 2 Doses Of Pfizer Covid Vaccine Within 21-28 Days
COVID-19 patients should take two doses of the new Pfizer/BioNTech vaccine within a period of 21-28 days, the head of the World Health Organization's immunization advisory group said on Tuesday.
-
No Evidence Covid Vaccine Will Work If Booster Dose Delayed: BioNTech
BioNTech and partner Pfizer warned on Monday that they had no evidence that their jointly developed vaccine will continue to protect against COVID-19 if the booster shot is given later than tested in trials.
-
Bulgaria Reports 4 Cases Of Side Effects From Pfizer Covid Vaccine
Four Bulgarians vaccinated against COVID-19 with the Pfizer/BioNTech vaccine developed mild to moderate side effects, Bulgarian Drug Agency executive director Bogdan Kirilov said on Monday.
-
BioNtech Founders Warn Of Covid Vaccine Supply Gaps: Report
BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in supply until other vaccines were rolled out.
-
US Nurse Tests Positive Over A Week After Receiving Pfizer Vaccine: Report
A 45-year-old nurse in California tested positive for COVID-19 more than a week after receiving Pfizer Inc's coronavirus vaccine, an ABC News affiliate reported on Tuesday.
-
Singapore Begins COVID-19 Vaccinations With Pfizer In One Of Asia's First
Singapore began vaccinating healthcare workers with Pfizer-BioNTech's COVID-19 vaccine on Wednesday, kicking off one of Asia's first inoculation programmes against a pandemic that has killed more than 1.7 million people globally.
-
Europe Begins Covid Vaccine Rollout Amid Fear Of New Virus Strain
A swath of EU nations begin vaccinating their most vulnerable groups Sunday as a reputedly more contagious coronavirus variant spread internationally and the WHO warned that the current pandemic would not be the last.
-
France Receives First Doses Of Pfizer COVID-19 Vaccine
France's first doses of the Pfizer-BioNTech coronavirus vaccine were delivered early Saturday to the Paris hospital system's central pharmacy outside the capital, an AFP journalist saw.
